Zachary Roberts
Vermögen: 362 938 $ am 31.07.2026
Vermögen: 362 938 $ am 31.07.2026
Zachary Roberts is currently President, Chief Executive Officer & Director at Allogene Therapeutics, Inc., starting in 2026.
Formerly, Dr. Roberts was Chief Medical Officer at Instil Bio, Inc. from 2020 to 2022, Vice President-Clinical Development at Kite Pharma, Inc. from 2018 to 2019, and Director-Clinical Medical Research at Amgen, Inc. in 2015.
Education includes undergraduate studies at the University of Maryland and a doctorate from the University of Maryland School of Medicine.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.07.2026 | 193 052 ( 0,06 % ) | 362 938 $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ALLOGENE THERAPEUTICS, INC. | Vorstandsvorsitzender | 01.07.2026 |
| Unternehmen | Position | Ende |
|---|---|---|
| INSTIL BIO, INC. | Technik-/Wissenschafts-/F&E-Leiter | 11.11.2022 |
| KITE PHARMA INC | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2019 |
| AMGEN INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2015 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
University of Maryland
University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maryland School of Medicine
University of Maryland School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kite Pharma, Inc.
Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
Allogene Therapeutics, Inc.
Allogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immuno-oncology | Health Technology |
Instil Bio, Inc.
Instil Bio, Inc. BiotechnologyHealth Technology Develops tumour infiltrating lymphocytes for the treatment of cancer | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen